Thomas Jefferson University in Philadelphia is in the process of developing a data base to register medical cannabis patients to study the positive or negative health benefits of consuming cannabis for a wide range of conditions. The prestigious University will do so on mmm.org and their goal is to register 100,000 patients by next year. The database will be overseen by the Lambert Center for the Study of Medical Cannabis and Hemp, which received $3M in fudging in 2016.
Since medical marijuana was legalized in Pennsylvania both private and public institutions have become interested in researching varieties of the cannabis sativa plant for medicinal purposes. By implementing a data base that contain a record of feedback from patients, scientists involved in the study can begin to pinpoint what ailments are best suited for different varieties of cannabis. With time the data should begin to help identify helpful information to the scientific community involved in studying cannabinoids.
Dr. Charles V. Pollack Jr., director of the Lambert Center said, “Current evidence indicates that cannabinoids can be useful in the management of certain types of chronic pain, side effects of chemotherapy and some symptoms of multiple sclerosis—but there is much we still need to learn.”
You may be interested
Cash Crop Today Interview with David Boissinot from TrimproEditor - October 23, 2018
Trimpro developes and manufactures top of the line, full service, trimming machines in Canada which can be shipped to growers throughout the world. The following is a…
OTC Markets Group Welcomes TerrAscend Corp. to OTCQXJaelynn Offerman - October 22, 2018
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced TerrAscend Corp. (CSE: TER; OTCQX: TRSSF), a biopharmaceutical and wellness company that…
Pivot Pharmaceuticals Signs Agreement with Licorera Del Sur Subsidiary Cartagena Inc. To Create Joint Venture To Commercialize Cannabis-Infused Non-Alcoholic BeveragesJaelynn Offerman - October 22, 2018
Pivot Pharmaceuticals, Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Letter of Intent to create a Joint Venture…